Nafarelin acetate hydrate

CAS: 86220-42-0

Ref. 3D-LDA22042

Produktinformation

• Name: Nafarelin acetate hydrate
• Synonyme: Nafarelin acetate [USAN], 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolylglycinamide acetate (salt) hydrate, Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-, acetate (salt), hydrate, Rs-94991-298, Luteinizing hormone-releasing factor (swine), 6-(3-(2-naphthalenyl)-D-alanine)-, acetate (salt), hydrate, NafarelinAcetate, (2S)-N-(2-amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-(2-methylpropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxopyrrolidin-2-yl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}pyrrolidine-2-carboxamide acetate (1:1) (non-preferred name), 5-Oxo-L-Prolyl-L-Histidyl-L-Tryptophyl-L-Seryl-L-Tyrosyl-3-(2-Naphthyl)-D-Alanyl-L-Leucyl-L-Arginyl-L-Prolylglycinamide Acetate Hydrate, Nafarelin acetate

Beschreibung

Nafarelin acetate hydrate is a synthetic analog of the natural hormone, gonadotropin-releasing hormone (GnRH). It is used in the treatment of endometriosis. Nafarelin acetate hydrate has been shown to desensitize nasal tissues and can be administered by nasal spray for the treatment of this condition. The drug also helps to reduce estrogen production, which may help to treat hypogonadism or anovulation. In addition, it may cause ovulation in some patients. Nafarelin acetate hydrate is a salt form with a porcine residue that is hydrolyzed in vivo to nafarelin, its active form.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 1,400.5 g/mol
• Formel: C₆₈H₈₉N₁₇O₁₆
• Reinheit: Min. 95%